Dietary Aloe Improves Insulin Sensitivity via the Suppression of Obesity-induced Inflammation in Obese Mice
2
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Background: Insulin resistance is an integral feature of metabolic syndromes, including obesity, hyperglycemia, and hyperlipidemia. In this study, we evaluated whether the aloe component could reduce obesity-induced inflammation and the occurrence of metabolic disorders such as blood glucose and insulin resistance. Methods: Male C57BL/6 obese mice fed a high-fat diet for 54 days received a supplement of aloe formula (PAG, ALS, Aloe QDM, and Aloe QDM complex) or pioglitazone (PGZ) and were compared with unsupplemented controls (high-fat diet; HFD) or mice fed a regular diet (RD). RT-PCR and western blot analysis were used to quantify the expression of obesity-induced inflammation. Results:Aloe QDM lowered fasting blood glucose and plasma insulin compared with HFD. Obesity-induced inflammatory cytokine (IL-1β, -6, -12, TNF-α) and chemokine (CX3CL1, CCL5)mRNA and protein were decreased markedly, as was macrophage infiltration and hepatic triglycerides by Aloe QDM. At the same time, Aloe QDM decreased the mRNA and protein of PPARγ/LXRα and 11β-HSD1 both in the liver and WAT. Conclusion: Dietary aloe formula reduces obesity-induced glucose tolerance not only by suppressing inflammatory responses but also by inducing anti-inflammatory cytokines in the WAT and liver, both of which are important peripheral tissues affecting insulin resistance. The effect of Aloe QDM complex in the WAT and liver are related to its dual action on PPARγ and 11β-HSD1 expression and its use as a nutritional intervention against T2D and obesity-related inflammation is suggested.
Abstract
Background: Insulin resistance is an integral feature of metabolic syndromes, including obesity, hyperglycemia, and hyperlipidemia. In this study, we evaluated whether the aloe component could reduce obesity-induced inflammation and the occurrence of metabolic disorders such as blood glucose and insulin resistance. Methods: Male C57BL/6 obese mice fed a high-fat diet for 54 days received a supplement of aloe formula (PAG, ALS, Aloe QDM, and Aloe QDM complex) or pioglitazone (PGZ) and were compared with unsupplemented controls (high-fat diet; HFD) or mice fed a regular diet (RD). RT-PCR and western blot analysis were used to quantify the expression of obesity-induced inflammation. Results:Aloe QDM lowered fasting blood glucose and plasma insulin compared with HFD. Obesity-induced inflammatory cytokine (IL-1β, -6, -12, TNF-α) and chemokine (CX3CL1, CCL5)mRNA and protein were decreased markedly, as was macrophage infiltration and hepatic triglycerides by Aloe QDM. At the same time, Aloe QDM decreased the mRNA and protein of PPARγ/LXRα and 11β-HSD1 both in the liver and WAT. Conclusion: Dietary aloe formula reduces obesity-induced glucose tolerance not only by suppressing inflammatory responses but also by inducing anti-inflammatory cytokines in the WAT and liver, both of which are important peripheral tissues affecting insulin resistance. The effect of Aloe QDM complex in the WAT and liver are related to its dual action on PPARγ and 11β-HSD1 expression and its use as a nutritional intervention against T2D and obesity-related inflammation is suggested.
참고문헌 (29)
- Pickup JC, "Is type II diabetes mellitus a disease of the innate immune system", Diabetologia, 41, pp.1241~1248 (1998)
- Grimble RF, "Inflammatory status and insulin resistance", Curr Opin Clin Nutr Metab Care, 5, pp.551~559 (2002)
- Xu H, "Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance", J Clin Invest, 112, pp.1821~1830 (2003)
- Weisberg SP, "Obesity is associated with macrophage accumulation in adipose tissue", J Clin Invest, 112, pp.1796~1808 (2003)
- Uysal KT, "Hotamisligil GS: Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function", Nature, 389, pp.610~614 (1997)
- Browning JD, "Molecular mediators of hepatic steatosis and liver injury", J Clin Invest, 114, pp.147~152 (2004)
- Steppan CM, "The hormone resistin links obesity to diabetes", Nature, 409, pp.307~312 (2001)
- Yang Q, "Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes", Nature, 436, pp.356~362 (2005)
- Olefsky JM, "Macrophages, inflammation, and insulin resistance", Annu Rev Physiol, 72, pp.219~246 (2010)
- Matsuzawa Y, "Adiponectin and metabolic syndrome", Arteriosclerosis, Thrombosis, and Vascular Biology, 24, pp.29~33 (2004)
- Hausman DB, "The biology of white adipocyte proliferation", Obes Rev, 2, pp.239~254 (2001)
- Hotamisligil GS, "Adipose expression of tumor necrosis factor-alpha: direct role in obesity- linked insulin resistance", Science, 259, pp.87~91 (1993)
- Wang P, "The secretory function of adipocytes in the physiology of white adipose tissue", J Cell Physiol, 216, pp.3~13 (2008)
- Josep BR, "Peroxisome proliferator- activated receptors: the nutritionally controlled molecular networks that integrate inflammation, immunity and metabolism", Current Nutrition & Food Science, 1, pp.179~187 (2005)
- Capasso F, "Aloe and its therapeutic use", Phytotherapy Research, 12, pp.S124~S127 (1998)
- Heggers JP, "Wound healing effects of Aloe gel and other topical antibacterial agents on rat skin", Phytotherapy Research, 9, pp.455~457 (1995)
- Koo MWL, "Aloe vera: Antiulcer and antidiabetic effects", Phytotherapy Research, 8, pp.461~464 (1994)
- Winters WD, "Effects of aloe extracts on human normal and tumor cells in vitro", Economic Botany, 35, pp.89~95 (1981)
- Yongchaiyudha S, "Antidiabetic activity of Aloe vera L. juice: I. Clinical trial in new cases of diabetes mellitus", Phytomedicine, 3, pp.241~243 (1996)
- Bunyapraphatsara N, "Antidiabetic activity of Aloe vera L. juice. II. Clinical trial in diabetes mellitus patients in combination with glibenclamide", Phytomedicine, 3, pp.245~248 (1996)
- Schwarz K, "Chromium(III) and the glucose tolerance factor", Arch Biochem Biophys, 85, pp.292~295 (1959)
- Anderson RA, "Chromium, glucose intolerance and diabetes", J Am Coll Nutr, 17, pp.548~555 (1998)
- Kim K, "Hypoglycemic and hypolipidemic effects of processed Aloe vera gel in a mouse model of non-insulin-dependent diabetes mellitus", PHYTOMEDICINE, 16, pp.856~863, ELSEVIER GMBH
- Kyungjae KIM, "Down-Regulation of Adipogenesis and Hyperglycemia in Diet-Induced Obesity Mouse Model by Aloe QDM", 응용약물학회지, 18(3), pp.336~342 (2010), 한국응용약물학회
- Odegaard JI, "Alternative M2 activation of Kupffer cells by PPARdelta ameliorates obesity-induced insulin resistance", Cell Metab, 7, pp.496~507 (2008)
- Kim J, "Differential modulation of 3T3-L1 adipogenesis mediated by 11beta-hydroxysteroid dehydrogenase-1 levels", J Biol Chem, 282, pp.11038~11046 (2007)
- Jung-Ok Kim, "Antihyperglycemic and Antioxidative Effects of New Herbal Formula in Streptozotocin-Induced Diabetic Rats", Journal of Medicinal Food, 12(4), pp.728~735 (2009), 한국식품영양과학회
- Stienstra R, "The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver", J Hepatol, 46, pp.869~877 (2007)
- Costet P, "Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor", retinoid X receptor, 2000, pp.275, 28240~28245